Amla and Cholesterol: What Human Studies Actually Show

For a broader overview of Amla, including its botanical identity, traditional use, whole-fruit preparations, and evidence limitations, explore our complete Amla guide.

Amla has been used in Ayurveda for centuries, but one modern claim has attracted particular attention:

Can Amla actually lower cholesterol?

Unlike many herbal claims that rely mostly on tradition or laboratory experiments, Amla has now been studied in randomized human trials and several systematic reviews.

The results are interesting.

Some studies have reported reductions in LDL cholesterol, total cholesterol and triglycerides. Some have also reported increases in HDL cholesterol. But the evidence is not as simple as saying, “Amla lowers cholesterol.”

The type of Amla used, the dose, the study population and the quality of the research all matter.

So what do the human studies actually show?

First, What Do LDL, HDL and Triglycerides Mean?

Before looking at Amla, it helps to understand what researchers are measuring.

LDL cholesterol is commonly called “bad cholesterol.” High LDL is associated with cholesterol accumulating within artery walls and is an important cardiovascular risk factor.

HDL cholesterol is often called “good cholesterol,” although cardiovascular risk is more complicated than simply trying to raise HDL.

Triglycerides are another type of fat circulating in the blood. High levels can also be associated with metabolic and cardiovascular risk.

When researchers study Amla and cholesterol, they usually measure several of these markers rather than looking at a single number.

The Big Picture: What Happens When Researchers Combine the Studies?

One of the best ways to evaluate an herbal claim is not to rely on a single positive study.

Researchers can perform a systematic review and meta-analysis.

In simple language, this means scientists search for all relevant studies meeting predefined standards and then statistically combine their results. It is somewhat like asking:

“Instead of trusting one experiment, what happens when we look at the evidence together?”

A 2023 systematic review and meta-analysis examined nine randomized controlled trials involving 535 adults. The amount of Amla used across the studies ranged from 500 mg to 1,500 mg per day, and studies lasted between 14 and 84 days.[1]

When the studies were combined, Amla was associated with an average LDL reduction of approximately 15 mg/dL compared with control treatment. Triglycerides decreased by about 22 mg/dL, and VLDL cholesterol also decreased.[1]

What does a 15 mg/dL LDL reduction mean?

Imagine someone starts with an LDL of 140 mg/dL.

A 15 mg/dL reduction would theoretically bring that value to around 125 mg/dL.

But this is only an illustration.

It does not mean that someone taking Amla should expect their LDL to fall by exactly 15 points. The results differed substantially from one study to another.

That difference between studies is extremely important.

The researchers reported considerable statistical variation, or heterogeneity, particularly for LDL. In everyday language, the studies did not all produce the same magnitude of benefit. The authors therefore described the findings as promising but said they should be interpreted cautiously.[1]

Another Meta-Analysis Found an Even Larger LDL Change

A separate systematic review examined four randomized trials involving 227 adults with dyslipidemia.[2]

After approximately 12 weeks, Amla extract was associated with an average reduction of roughly:

25 mg/dL in LDL cholesterol

and

21 mg/dL in total cholesterol.

HDL increased by approximately 4.7 mg/dL.

Interestingly, triglyceride reduction was not statistically significant in this analysis.[2]

That is a useful reminder that different reviews can reach somewhat different estimates depending on which studies are included and how they are analyzed.

The researchers also rated the overall evidence as low certainty and found substantial variation between the trials.[2]

So the proper conclusion is not:

“Amla definitely lowers LDL by 25 points.”

A better conclusion is:

Several randomized trials show a cholesterol-lowering signal, but we still do not know how large or consistent that effect would be in the general population.

A Third Review Found the Same General Pattern

Another 2023 meta-analysis included five randomized controlled trials.

The combined results showed statistically significant reductions in LDL cholesterol, total cholesterol and triglycerides, along with an increase in HDL cholesterol.[3]

The researchers also reported reductions in fasting glucose and C-reactive protein, an inflammatory marker.

However, the included interventions were relatively short — approximately 3 to 12 weeks — and the authors concluded that additional studies were needed to confirm the findings.[3]

This is important because when multiple reviews point in approximately the same direction, the finding becomes more interesting.

But multiple meta-analyses can contain some of the same underlying clinical trials, so they should not be treated as completely independent sets of hundreds of new participants.

One of the Strongest Individual Trials: 98 People With Dyslipidemia

A particularly interesting randomized, double-blind, placebo-controlled trial enrolled 98 adults with abnormal blood lipid levels.[4]

Half received a specific Amla extract.

The other half received a placebo designed to look similar.

Neither the participants nor the researchers assessing them knew who was receiving which treatment during the study. That design helps reduce bias.

Participants received:

500 mg Amla extract twice daily

for 12 weeks.

The extract was not ordinary powdered Amla fruit. It was a specific standardized extract containing polyphenols, triterpenoids and oils.[4]

What happened to LDL?

At the beginning of the trial, average LDL in the Amla group was approximately:

140 mg/dL

After 12 weeks:

112 mg/dL

The placebo group started at approximately 132 mg/dL and finished around 126 mg/dL.

The difference between groups was statistically significant.[4]

What happened to total cholesterol?

Average total cholesterol in the Amla group changed from approximately:

232 mg/dL → 177 mg/dL

The placebo group changed from approximately:

226 mg/dL → 213 mg/dL.[4]

And triglycerides?

Triglycerides fell from approximately:

261 mg/dL → 172 mg/dL

in the Amla group.

The placebo group also improved, but considerably less:

248 mg/dL → 210 mg/dL.[4]

Those numbers certainly make the study worth paying attention to.

But there are several reasons we should not immediately assume every Amla supplement will produce the same result.

First, the study tested a specific extract, not ordinary whole Amla fruit powder.

Second, the trial lasted only 12 weeks.

Third, although 98 participants is useful for an herbal clinical trial, it is still small compared with the thousands or tens of thousands of people often studied before major cardiovascular treatment recommendations are established.

The study was also sponsored by the manufacturer of the tested extract. The paper states that the funder did not participate in the study design, data analysis or decision to publish, but funding relationships are still worth knowing when evaluating evidence.[4]

Another Trial Asked an Interesting Question: Does the Dose Matter?

A separate randomized, double-blind, placebo-controlled trial studied 59 people with metabolic syndrome.[5]

Participants received either placebo or standardized aqueous Amla extract at:

250 mg twice daily

or

500 mg twice daily

for 12 weeks.

The researchers found that the higher-dose group had larger changes in several lipid measurements.

At 500 mg twice daily, the reported average percentage changes included approximately:

LDL: −21.8%

Total cholesterol: −11.1%

Triglycerides: −19.2%

HDL: +22.2%.[5]

The lower dose also showed improvements, but generally smaller ones.

In simple language, this study suggested something researchers often look for:

a possible dose-response relationship.

If a higher dose consistently produces a greater effect than a lower dose, that can make the biological finding more convincing.

But again, this trial tested a standardized aqueous extract. It did not establish that the same percentages would occur from ordinary dried Amla powder.[5]

What About Studies Comparing Amla With Statins?

This is where interpretation becomes especially important.

A small 2012 study enrolled 60 people with elevated cholesterol. Forty received 500 mg of Amla daily, while 20 received 20 mg of simvastatin daily for 42 days.[6]

Both groups showed improvements in total cholesterol, LDL, triglycerides and HDL.[6]

You may sometimes see this study used online to claim:

“Amla works like a statin.”

That is not a justified conclusion.

The trial was small, short, and its design was not strong enough to establish that Amla and simvastatin are clinically equivalent.

Most importantly, statins have extensive evidence showing reductions in cardiovascular events in appropriate patients. Amla does not currently have comparable long-term outcome evidence demonstrating that it prevents heart attacks or strokes.

So this study is historically interesting, but it should not be used as a reason to replace prescribed cholesterol medication with Amla.

What Does More Recent Research Show?

A 2025 peer-reviewed open-label study followed people with abnormal lipid levels who received 500 mg Amla extract twice daily for 90 days after an initial lifestyle intervention.[7]

Researchers reported significant reductions in LDL, total cholesterol, triglycerides, VLDL and an atherogenic index. HDL did not significantly change.[7]

This adds to the overall picture, but an open-label study is weaker evidence than a blinded placebo-controlled trial.

Why?

Because participants know what they are taking, and without a parallel placebo comparison it becomes harder to separate the effect of the supplement from diet changes, exercise, expectations, natural variation or other factors.

It is supportive evidence — not definitive evidence.

Why Might Amla Affect Cholesterol?

Scientists have proposed several possible mechanisms.

Amla fruit contains polyphenols, tannins and other naturally occurring compounds. Experimental research has suggested possible effects on cholesterol synthesis, oxidation, inflammation and lipid metabolism.

Some researchers have proposed that Amla compounds may influence enzymes involved in cholesterol production or alter LDL-receptor activity.[4]

But a plausible biological mechanism is not the same thing as proving a clinical benefit.

Many substances show interesting activity in a laboratory but produce much smaller or inconsistent effects in real people.

That is why the human trials matter most.

The Most Important Limitation: Most Research Used Extracts

This may be the most important point in the entire article.

The words “Amla” on two bottles do not necessarily mean the products are scientifically equivalent.

Many of the stronger cholesterol studies used specific standardized extracts.

An extract concentrates or selects components from the fruit through processing.

Whole-fruit powder is different. It contains dried and milled fruit material with its naturally occurring mixture of components, but at different concentrations.

Therefore:

A study using 500 mg of a standardized Amla extract cannot automatically be used to claim that 500 mg — or even 1,500 mg — of whole Amla powder will produce the same cholesterol effect.

The reverse is also true.

This is why responsible supplement education should always identify what preparation was actually studied.

So, Does Amla Lower Cholesterol?

Based on the human evidence available today, the fairest answer is:

Possibly — and the evidence is more substantial than for many herbal cholesterol claims.

Multiple randomized trials and several systematic reviews have found reductions in LDL and total cholesterol after supplementation with certain Amla preparations.[1][2][3]

However, several limitations remain.

The total number of clinical trials is still relatively small. Many studies are short. The preparations differ. Results vary substantially between studies. Several trials involve specific proprietary extracts. And we do not yet have strong evidence showing that Amla supplementation reduces actual cardiovascular events such as heart attacks or strokes.

So the evidence supports continued research, not the statement that Amla is a proven treatment for high cholesterol.

Can Amla Replace a Statin?

No.

Someone prescribed a statin should not stop or reduce it because of an Amla study or supplement claim.

Cholesterol treatment is based on more than a laboratory number. Physicians consider overall cardiovascular risk, age, diabetes, blood pressure, smoking history, family history and existing cardiovascular disease.

Amla may be scientifically interesting as a botanical being studied for lipid health, but that is very different from being an established replacement for cholesterol-lowering therapy.

Anyone using cholesterol medication who is considering an herbal supplement should discuss it with their healthcare professional.

What Should Consumers Take Away From the Research?

The interesting story is not that ancient tradition has suddenly been “proven.”

It is that an Ayurvedic fruit has produced a repeatable enough signal in human cholesterol studies to justify serious scientific investigation.

That deserves attention.

At the same time, the details matter.

The strongest evidence so far relates primarily to specific Amla extracts, generally studied for weeks rather than years.

Research has not established that every Amla powder, tablet, juice or extract will produce the same effect.

And it has not established Amla as a substitute for standard cholesterol treatment.

The Bottom Line

Amla and cholesterol is no longer a topic supported only by tradition.

Human randomized trials and meta-analyses have reported potentially meaningful reductions in LDL cholesterol, total cholesterol and, in several studies, triglycerides.

That makes the research genuinely interesting.

But promising evidence is not the same as proven treatment.

The most scientifically accurate conclusion today is:

Certain Amla extracts have shown cholesterol-lowering effects in human clinical studies, particularly for LDL and total cholesterol. However, the evidence remains limited by small trials, short study durations, differing formulations and substantial variation between studies. More large, independent and long-term clinical trials are needed.

And perhaps the most important question when someone says, “Research proves Amla lowers cholesterol,” is:

Which Amla preparation did the research actually use?

Research & References

[1] Brown PDS, Ketter N, Vis-Dunbar M, Sakakibara BM.
Clinical effects of Emblica officinalis fruit consumption on cardiovascular disease risk factors: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies. 2023;23:190. DOI: 10.1186/s12906-023-03997-8. PMID: 37296402. Nine randomized trials, 535 participants.

[2] Acampado LRT, Chiu HHC, Larrazabal RB Jr, et al.
The Efficacy and Safety of Emblica officinalis Aqueous Fruit Extract among Adult Patients with Dyslipidemia: A Systematic Review and Meta-analysis. Acta Medica Philippina. 2023;57(5):90–95. DOI: 10.47895/amp.vi0.5047. PMID: 39678212. Four randomized trials, 227 participants; authors rated the evidence low certainty.

[3] Setayesh L, Haghighat N, Rasaei N, et al.
The impact of Emblica officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. Diabetes & Metabolic Syndrome. 2023;17(3):102729. DOI: 10.1016/j.dsx.2023.102729. PMID: 36934568.

[4] Randomized, double-blind, placebo-controlled multicenter dyslipidemia trial.
A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia. BMC Complementary and Alternative Medicine. 2019. DOI: 10.1186/s12906-019-2430-y. PMID: 30670010. Ninety-eight participants; 500 mg extract twice daily for 12 weeks.

[5] Usharani P, Merugu PL, Nutalapati C.
Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study. BMC Complementary and Alternative Medicine. 2019;19:97. DOI: 10.1186/s12906-019-2509-5. PMID: 31060549.

[6] Gopa B, Bhatt J, Hemavathi KG.
A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with simvastatin. Indian Journal of Pharmacology. 2012;44(2):238–242. DOI: 10.4103/0253-7613.93857. PMID: 22529483.

[7] Jagalurappa K, Vrushabaiah GK, Govindaraj S.
Effect of Emblica officinalis (Amla) Extract Versus Exercise on Lipid Levels in Participants With Abnormal Lipid Levels: An Open-Label Clinical Study. Current Therapeutic Research. 2025;103:100800. DOI: 10.1016/j.curtheres.2025.100800. PMID: 40621119.

Terms & Policies

©GeVica2026. All rights reserved. Operated by GenVexa Biosciences LLC, Plano, Texas, USA

Contact us

Gevica Biosciences

Customer care: +1 (469) 618-8255

Support@GeVica.com

1520 Preston Road, Apt 1213, Plano TX 75093

Terms & Conditions

Privacy

Refunds

Shipping

Disclaimer

No Hype, No Gimmicks, Just Herbs.

WhatsApp Customer Support